Antiviral and Immunoregulatory Effects of Indoleamine-2,3-Dioxygenase in Hepatitis C Virus Infection

Journal of Innate Immunity

Volumn 7, Issue , 2015, Pages 530-544

  Lepiller, Quentin ^a,b   Soulier, Eric ^b   Li, Qisheng ^d   Lambotin, Mélanie ^b   Barths, Jochen ^b   Fuchs, Dietmar ^c   Stoll Keller, Françoise ^a,b   Liang, T Jake ^d   Barth, Heidi ^a,b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Antiviral immune response; Hepatitis C virus; Hepatocyte; Indoleamine 2,3 dioxygenase

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CLAUDIN 1; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON REGULATORY FACTOR 1; KYNURENINE; MESSENGER RNA; SMALL INTERFERING RNA; STAT1 PROTEIN; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN; INTERFERON; IRF1 PROTEIN, HUMAN;

ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; CD4+ T LYMPHOCYTE; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE INDUCTION; GENE SILENCING; GENETIC TRANSCRIPTION; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INNATE IMMUNITY; LIVER CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; TRANSCRIPTION INITIATION; TRANSIENT TRANSFECTION; UPREGULATION; VIRAL CLEARANCE; VIRUS REPLICATION; WESTERN BLOTTING; CELL CULTURE; CELL PROLIFERATION; GENETICS; HEPACIVIRUS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; PHYSIOLOGY; VIROLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON REGULATORY FACTOR-1; INTERFERONS; RNA, SMALL INTERFERING; STAT1 TRANSCRIPTION FACTOR; VIRUS REPLICATION;

EID: 84941997781     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000375161     Document Type: Article

References (47)

1. Liang TJ, Heller T: Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 2004; 127:S62-S71.
2. Horner SM, Gale M: Regulation of hepatic innate immunity by hepatitis C virus. Nat Med 2013; 19: 879-888.
3. Rehermann B: Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med 2013; 19: 859-868.
4. Mellor AL, Munn DH: IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4: 762-774.
5. Pfefferkorn ER: Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984; 81: 908-912.
6. Adams O, Besken K, Oberdorfer C, MacKenzie CR, Takikawa O, Daubener W: Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J Virol 2004; 78: 2632-2636.
7. Mao R, Zhang J, Jiang D, Cai D, Levy JM, Cuconati A, Block TM, Guo JT, Guo H: Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. J Virol 2010; 85: 1048-1057.
8. Yeung AW, Wu W, Freewan M, Stocker R, King NJ, Thomas SR: Flavivirus infection induces indoleamine 2,3-dioxygenase in human monocyte-derived macrophages via tumor necrosis factor and NF-?B. J Leuk Biol 2012; 91: 657-666.
9. Curti A, Trabanelli S, Salvestrini V, Baccarani M, Lemoli RM: The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood 2009; 113: 2394-2401.
10. Barth H, Raghuraman S: Persistent infection diseases say-IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy. Crit Rev Microbiol 2014; 40: 360-368.
11. Boasso A, Herbeuval JP, Hardy AW, Anderson SA, Dolan MJ, Fuchs D, Shearer GM: HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007; 109: 3351-3359.
12. Nilsson J, Boasso A, Velilla PA, Zhang R, Vaccari M, Franchini G, Shearer GM, Andersson J, Chougnet C: HIV-1-driven regulatory Tcell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006; 108: 3808-3817.
13. Cozzi A, Zignego AL, Carpendo R, Biagiotti T, Aldinucci A, Monti M, Giannini C, Rosselli M, Laffi G, Moroni F: Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. J Viral Hepat 2006; 13: 402-408.
14. Larrea E, Riezu-Boj JI, Gil-Guerrero L, Casares N, Aldabe R, Sarobe P, Civeira MP, Heeney JL, Rollier C, Verstrepen B, Wakita T, Borras-Cuesta F, Lasarte JJ, Prieto J: Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection. J Virol 2007; 81: 3662-3666.
15. Zignego AL, Cozzi A, Carpenedo R, Giannini C, Rosselli M, Biagioli T, Aldinucci A, Laffi G, Moroni F: HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment. Dig Liver Dis 2007; 39(suppl 1): S107-S111.
16. Higashitani K, Kanto T, Kuroda S, Yoshio S, Matsubara T, Kakita N, Oze T, Miyazaki M, Sakakibara M, Hiramatsu N, Mita E, Imai Y, Kasahara A, Okuno A, Takikawa O, Hayashi N, Takehara T: Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection. J Gastroenterol 2013; 48: 660-670.
17. Rollier CS, Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, Drexhage JA, Fagrouch Z, Berland JL, Komurian-Pradel F, Duverger B, Himoudi N, Staib C, Meyr M, Whelan M, Whelan JA, Adams VC, Larrea E, Riezu JI, Lasarte JJ, Bartosch B, Cosset FL, Spaan WJ, Diepolder HM, Pape GR, Sutter G, Inchauspe G, Heeney JL: Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity. Hepatology 2007; 45: 602-613.
18. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV: Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005; 102: 9294-9299.
19. Bartosch B, Dubuisson J, Cosset FL: Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 2003; 197: 633-642.
20. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11: 791-796.
21. Lambotin M, Baumert TF, Barth H: Distinct intracellular trafficking of hepatitis C virus in myeloid and plasmacytoid dendritic cells. J Virol 2010; 84: 8964-8969.
22. Thomas SR, Terentis AC, Cai H, Takikawa O, Levina A, Lay PA, Freewan M, Stocker R: Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide. J Biol Chem 2007; 282: 23778-23787.
23. Laich A, Neurauter G, Widner B, Fuchs D: More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem 2002; 48: 579-581.
24. Braun D, Longman RS, Albert ML: A twostep induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 2005; 106: 2375-2381.
25. Li Q, Pene V, Krishnamurthy S, Cha H, Liang TJ: Hepatitis C virus infection activates an innate pathway involving IKK-? in lipogenesis and viral assembly. Nat Med 2013; 19: 722-729.
26. Li Q, Brass AL, Ng A, Hu Z, Xavier RJ, Liang TJ, Elledge SJ: A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci USA 2009; 106: 16410-16415.
27. Thomas E, Gonzalez VD, Li Q, Modi AA, Chen W, Noureddin M, Rotman Y, Liang TJ: HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology 2012; 142: 978-988.
28. Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, Zeuge U, Windisch MP, Trippler M, Lohmann V, Binder M, Frese M, Bartenschlager R: Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Hepatology 2012; 56: 2082-2093.
29. Ball HJ, Sanchez-Perez A, Weiser S, Austin CJ, Astelbauer F, Miu J, McQuillan JA, Stocker R, Jermiin LS, Hunt NH: Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 2007; 396: 203-213.
30. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM: Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007; 446: 801-805.
31. Nguyen H, Hiscott J, Pitha PM: The growing family of interferon regulatory factors. Cytokine Growth Factor Rev 1998; 8: 293-312.
32. Jeong YI, Kim SW, Jung ID, Lee JS, Chang JH, Lee CM, Chun SH, Yoon MS, Kim GT, Ryu SW, Kim JS, Shin YK, Lee WS, Shin HK, Lee JD, Park YM: Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase C?-STAT1 signaling pathway in interferon-?-stimulated murine dendritic cells. J Biol Chem 2009; 284: 3700-3708.
33. Lindenbach BD, Rice CM: The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol 2013; 11: 688-700.
34. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM: A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011; 472: 481-485.
35. Blackham S, Baillie A, Al-Hababi F, Remlinger K, You S, Hamatake R, McGarvey MJ: Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus. J Virol 2010; 84: 5404-5414.
36. Abbate I, Romano M, Longo R, Cappiello G, Lo Iacono O, Di Marco V, Paparella C, Spano A, Capobianchi MR: Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients. J Med Virol 2003; 70: 581-587.
37. Kanazawa N, Kurosaki M, Sakamoto N, Enomoto N, Itsui Y, Yamashiro T, Tanabe Y, Maekawa S, Nakagawa M, Chen CH, Kakinuma S, Oshima S, Nakamura T, Kato T, Wakita T, Watanabe M: Regulation of hepatitis C virus replication by interferon regulatory factor 1. J Virol 2004; 78: 9713-9720.
38. Chon SY, Hassanain HH, Gupta SL: Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-?-inducible expression of human indoleamine 2,3-dioxygenase gene. J Biol Chem 1996; 271: 17247-17252.
39. Bartenschlager R, Pietschmann T: Efficient hepatitis C virus cell culture systems: what a difference the host cell makes. Proc Natl Acad Sci USA 2005; 102: 9739-9740.
40. Ramsauer K, Farlik M, Zupkovitz G, Seiser C, Kroger A, Hauser H, Decker T: Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-?-inducible gbp2 gene. Proc Natl Acad Sci USA 2007; 104: 2849-2854.
41. Burdeinick-Kerr R, Govindarajan D, Griffin DE: Noncytolytic clearance of Sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling. J Virol 2009; 83: 3429-3435.
42. Trilling M, Le VT, Rashidi-Alavijeh J, Katschinski B, Scheller J, Rose-John S, Androsiac GE, Jonjic S, Poli V, Pfeffer K, Hengel H: 'Activated' STAT proteins: a paradoxical consequence of inhibited Jak-STAT signaling in cytomegalovirus-infected cells. J Immunol 2014; 192: 447-458.
43. Sohn SY, Hearing P: Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits stat dephosphorylation. J Virol 2011; 85: 7555-7562.
44. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, Orabona C, Bianchi R, Belladonna ML, Volpi C, Santamaria P, Fioretti MC, Puccetti P: The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ?-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006; 176: 6752-6761.
45. Forouhar F, Anderson JL, Mowat CG, Vorobiev SM, Hussain A, Abashidze M, Bruckmann C, Thackray SJ, Seetharaman J, Tucker T, Xiao R, Ma LC, Zhao L, Acton TB, Montelione GT, Chapman SK, Tong L: Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase. Proc Natl Acad Sci USA 2007; 104: 473-478.
46. Schmidt SK, Muller A, Heseler K, Woite C, Spekker K, MacKenzie CR, Daubener W: Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase. Eur J Immunol 2009; 39: 2755-2764.
47. Muller A, Heseler K, Schmidt SK, Spekker K, Mackenzie CR, Daubener W: The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects. J Cell Mol Med 2009; 13: 1125-1135.